Provided By GlobeNewswire
Last update: Aug 21, 2025
IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at three upcoming investor conferences (all Eastern Time):
Read more at globenewswire.com26.78
-0.01 (-0.04%)
Find more stocks in the Stock Screener



